Clinical Trials in Phoenix

Showing 10041-10060 of 16,646 trials

BeWell24: Smartphone-based Diabetes Prevention in the VA

NCT03202277

Type 2 diabetes (T2D) is a national epidemic and current lifestyle programs and medications are not effectively managing the crisis. This project aims to test a novel smartphone-delivered intervention that simultaneously targets multiple health behaviors (i.e., sleep, sedentary behavior, physical activity,dietary intake) within clinical settings at a large Veteran Health Administration regional hospital. If effective, this project has potential for large-scale implementation nationwide through the VA healthcare system and broad applicability for other populations at T2D risk as well as other disorders.

Diabetes Mellitus, Type 2

Arizona State University120 participantsStarted Sep 2017

Phoenix, Arizona, United States • Tempe, Arizona, United States

COMPLETEDPhase 3< 1 mile

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

NCT02666664

The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.

HypercholesterolemiaAtherosclerotic Cardiovascular Diseases

Esperion Therapeutics, Inc.2,230 participantsStarted Jan 2016

Huntsville, Alabama, United States • Cottonwood, Arizona, United States • Phoenix, Arizona, United States +101 more locations

BeWell24: Smartphone-based Diabetes Prevention in the VA

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Find Trials by Condition in Phoenix

Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis

PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Efficacy and Safety of UGN-101 in Recurrent Patients

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Clozapine for Cannabis Use in Schizophrenia

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

Study of PlasmaCap IG in Adults and Children With PIDD

Rituximab in New Onset Type 1 Diabetes

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ